Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1–27
Headlines
27
Sources here
5
Companies here
6
Current section Brazil Diagnostics & Research news
Latest

finance.yahoo.com Earnings

This Healthcare Services Stock Has 37% Upside

Well-known pharmaceutical companies such as Merck and Pfizer typically manage this complex process in house. Medpace Holdings which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2026 revenue guidance on July’s second-quarter conference call to a midpoint of $2.85 billion, corresponding to a year-over-year increase of 13%. Three months later, Medpace is in the …

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

I1DX34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% · Next-week setup negative 31.9% I1DX34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

BMRN vs. ILMN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Illumina (ILMN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. …

I1LM34 mentioned
Sharemaestro market context Trend signal active 52 weeks +78.4% I1LM34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IQV Stock Gains 42% in 3 Months: Here's What You Should Know

IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the Zacks S&P 500 Composite's 3.4% uptick. 3-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us …

I1QV34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +1.9% · Next-week setup negative 23.7% I1QV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

The transaction establishes an independent company, with the Microbiology business providing the foundation of a global microbiology diagnostics platform serving the clinical, food safety and pharmaceutical markets. The investment reflects Astorg's focused healthcare strategy and distinctive approach to complex transactions, combining deep sector expertise, …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass., August 12, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, forconsideration of approximately $1.075 billion, consisting of …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030

Company Logo Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific's Q2 2026 revenue beat, Hamamatsu Photonics' launch of its dedicated Lasers & Fibers Business Unit, and BD's $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stock futures little changed as traders await inflation report

[Wall Street-Street Sign] P_Wei/E+ via Getty Images Stock index futures were muted on Wednesday as traders turned their attention to a closely watched consumer inflation report that could offer fresh clues on the Federal Reserve's policy path. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.01%, S&P 500 …

A1GI34 mentioned
Sharemaestro market context Trend signal started 52 weeks +14.6% · Next-week setup negative 27.8% A1GI34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?

Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IDEXX (IDXX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Mike Erickson Chief Financial Officer - Andrew Emerson Vice President, Investor Relations - John Ravis Full Conference Call Transcript Operator: Good morning, …

I1DX34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% · Next-week setup negative 31.9% I1DX34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

The Zacks Analyst Blog Highlights Illumina, Qnity Electronics and nVent Electric

For Immediate Release Chicago, IL – August 11, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in …

I1LM34 main company
Sharemaestro market context Trend signal active 52 weeks +78.4% I1LM34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher Scientific and The Michael J. Fox Foundation expanded the Parkinson's Precision Medicine Initiative (PPMI) proteomic data resource. Scale: Approximately 5,500 research samples were analyzed using …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

New test brings quantitative cardiac assessment for cats and dogs into everyday workflows WESTBROOK, Maine, August 11, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst™ proBNP Test, the first and only dual-species, …

I1DX34 main company
Sharemaestro market context Price above Trend Line 52 weeks -13.6% · Next-week setup negative 31.9% I1DX34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering. The global non-viral transfection reagents market …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.17%, S&P 500 futures (SPX …

I1QV34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +1.9% · Next-week setup negative 23.7% I1QV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Sector Update: Healthcare Stocks Gain Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.4%.The iShares Biotechnology ETF (IBB) climbed 1%.In corporate news, Eli Lilly (LLY) received UK authorization for Silver Upgrade …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

How Investors Are Reacting To Thermo Fisher Scientific (TMO) New FDA-Cleared Multiple Myeloma Platform

In late July 2026, Thermo Fisher Scientific used the ADLM conference in Anaheim to highlight new FDA-cleared diagnostic platforms, including the EXENT Solution for multiple myeloma and EliA CTD 13 Screen for systemic autoimmune connective tissue diseases, alongside expanded digital and quality-control offerings for …

TMOS34 main company
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Sector Update: Healthcare Stocks Rise in Afternoon Trading

Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index up 0.9% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Beat the Market Like Zacks: Aveanna, FactSet, Shopify in Focus

Last Friday, the three major Wall Street indexes closed a winning week. The Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average gained 5.2%, 3.6% and 3%, respectively. Wall Street's strong weekly performance was driven by renewed investor optimism over the U.S. …

TMOS34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?

Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but …

TMOS34 main company DHER34 mentioned
Sharemaestro market context Price above Trend Line 52 weeks +14.1% TMOS34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook

In late July and early August 2026, IQVIA Holdings and Medera announced a collaboration pairing IQVIA's global clinical and commercialization infrastructure with Medera's Sardocor and Novoheart cardiac gene therapy and human-based drug discovery platforms, alongside IQVIA's second-quarter results, raised full-year 2026 revenue guidance to …

I1QV34 main company
Sharemaestro market context Price above Trend Line 52 weeks +1.9% · Next-week setup negative 23.7% I1QV34 stored weekly price path from 15 Aug 2025 to 7 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context